ArticleInternational journal of molecular sciences2021

Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis.

Loreto Martínez-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.